Comparison of Neutralizing Antibody Titers Against Outbreak-Associated Measles Genotypes (D4, H1 and B3) in Iran Publisher Pubmed



Fatemi Nasab GS^{1, 2} ; Salimi V^{1, 2} ; Abbasi S^{1, 2} ; Adjami Nezhad Fard F^{1, 2} ; Mokhtari Azad T^{1, 2} Show Affiliations
Source: Pathogens and disease Published:2016

Abstract

Despite the accessibility of a promising vaccine, outbreaks of the measles virus (MV) take place even in well-vaccinated populations. D4, H1 and B3 genotypes have been detected regularly in different regions of Iran. These observations highlight the necessity of evaluating the protective efficacy of the vaccine against currently circulating MV genotypes during the elimination phase. A focus reduction neutralization test has been developed to measure the neutralizing antibodies against different genotypes of MV, such as H1, D4, B3 and vaccine strain (A), in children after second doses of measles vaccine. The geometric mean titer (GMT) rates of the sera against D4, H1, B3 and A genotypes were 95.9, 90.5, 32.0 and 76.1, respectively. Low GMTs of antibody against the B3 genotype compared with the other genotypes were indicated. Based on the current study results, the MV antibody titers in the sera of vaccinated cases are sufficient to neutralize all circulating genotypes in Iran; however, neutralizing antibody titers were lower for the B3 genotype than for the H1, D4 and A genotypes. The heterogeneous nature of MV, for instance the nucleotide sequence diversity between different strains, necessitates the evaluation of the protective efficacy of the vaccine against measles B3 genotype in countries where this virus has been the most commonly identified circulating genotype. © FEMS 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.